| 臺大學術典藏 |
2021-07-03T03:33:31Z |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
Liu C.-H.;Shih Y.-L.;Yang S.-S.;Lin C.-L.;Fang Y.-J.;Cheng P.-N.;Chen C.-Y.;Peng C.-Y.;Hsieh T.-Y.;Chiu Y.-C.;Su T.-H.;Liu C.-J.;Yang H.-C.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:20Z |
Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma
|
Huang B.-Y.; Tsai M.-R.; Hsu J.-K.; Lin C.-Y.; Lin C.-L.; Hu J.-T.; Huang Y.-W.; Liu C.-J.; Wu W.-J.; Wu C.-F.; Sung F.-Y.; PEI-JER CHEN; Liang H.-J.; Lin S.-M.; Yu M.-W. |
| 臺大學術典藏 |
2021-07-02T03:41:41Z |
Notch Ligand Delta-Like 4-Pretreated Dendritic Cells Alleviate Allergic Airway Responses by Enhancing IL-10 Production
|
Huang H.-M.; Hsiao G.; Fan C.-K.; Lin C.-L.; Leu S.-J.; BOR-LUEN CHIANG; Lee Y.-L. |
| 臺大學術典藏 |
2021-07-02T03:41:22Z |
Correction: Notch ligand delta-like 4-pretreated dendritic cells alleviate allergic airway responses by enhancing IL-10 production (PLoS ONE (2013) 8:5 (e63613) DOI: 10.1371/journal.pone.0063613)
|
Huang H.-M.; Hsiao G.; Fan C.-K.; Lin C.-L.; Leu S.-J.; BOR-LUEN CHIANG; Lee Y.-L. |
| 臺大學術典藏 |
2021-07-02T02:35:41Z |
Primary aldosteronism associated with severe hypokalemic rhabdomyolysis
|
Tsai W.-T.; Chen Y.-L.; WEI-SHIUNG YANG; Lin H.-D.; Chien C.-C.; Lin C.-L. |
| 臺大學術典藏 |
2021-06-24T07:16:58Z |
ITPKC gene SNP rs28493229 and Kawasaki disease in Taiwanese children
|
Chi H.; Huang F.-Y.; Chen M.-R.; Chiu N.-C.; Lee H.-C.; Lin S.-P.; Chen W.-F.; Lin C.-L.; Chan H.-W.; Liu H.-F.; LI-MIN HUANG; Lee Y.-J. |
| 臺大學術典藏 |
2021-06-22T02:01:26Z |
Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free mice
|
Wu, W.-K.;Chen, C.-C.;Liu, P.-Y.;Panyod, S.;Liao, B.-Y.;Chen, P.-C.;Kao, H.-L.;Kuo, H.-C.;Kuo, C.-H.;Chiu, T.H.T.;Chen, R.-A.;Chuang, H.-L.;Huang, Y.-T.;Zou, H.-B.;Hsu, C.-C.;Chang, T.-Y.;Lin, C.-L.;Ho, C.-T.;Yu, H.-T.;Sheen, L.-Y.;Wu, M.-S.; Wu, W.-K.; Chen, C.-C.; Liu, P.-Y.; Panyod, S.; Liao, B.-Y.; Chen, P.-C.; Kao, H.-L.; Kuo, H.-C.; Kuo, C.-H.; Chiu, T.H.T.; Chen, R.-A.; Chuang, H.-L.; Huang, Y.-T.; Zou, H.-B.; Hsu, C.-C.; Chang, T.-Y.; Lin, C.-L.; Ho, C.-T.; Yu, H.-T.; Sheen, L.-Y.; Wu, M.-S.; LEE-YAN SHEEN |
| 臺大學術典藏 |
2021-06-04T06:23:06Z |
Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free mice
|
Wu W.-K.;Chen C.-C.;Liu P.-Y.;Panyod S.;Liao B.-Y.;Chen P.-C.;Kao H.-L.;Kuo H.-C.;Ching-Hua Kuo;Chiu T.H.T.;Chen R.-A.;Chuang H.-L.;Huang Y.-T.;Zou H.-B.;Hsu C.-C.;Chang T.-Y.;Lin C.-L.;Ho C.-T.;Yu H.-T.;Sheen L.-Y.;Wu M.-S.; Wu W.-K.; Chen C.-C.; Liu P.-Y.; Panyod S.; Liao B.-Y.; Chen P.-C.; Kao H.-L.; Kuo H.-C.; CHING-HUA KUO; Chiu T.H.T.; Chen R.-A.; Chuang H.-L.; Huang Y.-T.; Zou H.-B.; Hsu C.-C.; Chang T.-Y.; Lin C.-L.; Ho C.-T.; Yu H.-T.; Sheen L.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-31T06:18:06Z |
Free fatty acids act as endogenous ionophores, resulting in Na+ and Ca2+ influx and myocyte apoptosis
|
Fang K.-M.; Lee A.-S.; MING-JAI SU; Lin C.-L.; Chien C.-L.; Wu M.-L. |
| 臺大學術典藏 |
2021-05-31T06:18:02Z |
Intracellular zinc release-activated ERK-dependent GSK-3Β-p53 and Noxa-Mcl-1 signaling are both involved in cardiac ischemic-reperfusion injury
|
Lin C.-L.; Tseng H.-C.; Chen W.-P.; MING-JAI SU; Fang K.-M.; Chen R.-F.; Wu M.-L. |
| 臺大學術典藏 |
2021-05-31T06:18:02Z |
Intracellular zinc release-activated ERK-dependent GSK-3Β-p53 and Noxa-Mcl-1 signaling are both involved in cardiac ischemic-reperfusion injury
|
Lin C.-L.; Tseng H.-C.; Chen R.-F.; Chen W.-P.; MING-JAI SU; Fang K.-M.; Wu M.-L. |
| 臺大學術典藏 |
2021-05-31T06:17:53Z |
Single allele Lmbrd1 knockout results in cardiac hypertrophy
|
Tseng L.T.-L.; Lin C.-L.; Pan K.-H.; Tzen K.-Y.; MING-JAI SU; Tsai C.-T.; Li Y.-H.; Li P.-C.; Chiang F.-T.; Chang S.C.; Chang M.-F. |
| 臺大學術典藏 |
2021-05-24T07:20:57Z |
Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma
|
Lin C.-L.; CHEN-HUA LIU; Chen W.; Huang W.-L.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:49Z |
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
|
Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; CHEN-HUA LIU; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:46Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:46Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:44Z |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up
|
Yu M.-L.; Lee C.-M.; Chen C.-L.; Chuang W.-L.; Lu S.-N.; CHEN-HUA LIU; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Kao J.-H.; Su W.-W.; Lin C.-L.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Liu C.-J. |
| 臺大學術典藏 |
2021-05-24T07:20:36Z |
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients
|
Wang C.-C.; CHEN-HUA LIU; Lin C.-L.; Wang P.-C.; Tseng T.-C.; Lin H.H.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:36Z |
Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B
|
Lin C.-L.; CHEN-HUA LIU; Wang C.-C.; Liang C.-C.; Su T.-H.; Liu C.-J.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:35Z |
Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping
|
CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:34Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
CHEN-HUA LIU; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2021-05-24T07:20:33Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
CHEN-HUA LIU; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2021-05-24T07:20:26Z |
Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan
|
CHEN-HUA LIU; Yu M.-L.; Peng C.-Y.; Hsieh T.-Y.; Huang Y.-H.; Su W.-W.; Cheng P.-N.; Lin C.-L.; Lo C.-C.; Chen C.-Y.; Chen J.-J.; Ma Q.; Brooks-Rooney C.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:23Z |
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study
|
CHEN-HUA LIU; Yu M.-L.; Peng C.-Y.; Hsieh T.-Y.; Huang Y.-H.; Su W.-W.; Cheng P.-N.; Lin C.-L.; Lo C.-C.; Chen C.-Y.; Chen J.-J.; Ma Q.; Brooks-Rooney C.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:21Z |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
CHEN-HUA LIU; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
